MIRA ▼ -1.3% - MIRA Pharmaceuticals, Inc. $MIRA - MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND MIRA Pharmaceuticals shares fell 1.3% today as the company advanced its non-opioid oral candidate MIRA-55 toward an Investigational New Drug application for inflammatory pain treatment. The decline may reflect investor caution around early-stage development timelines despite the clinical progress, or profit-taking following prior gains in the stock. 01-SEP-2026 08:00 AM ET